Indivior Pharmaceuticals, Inc. (INDV)
31.35
+0.81
(+2.65%)
USD |
NASDAQ |
Apr 13, 15:10
Indivior Pharmaceuticals EPS Diluted (Quarterly) : 0.816 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Liquidia Corp. | 0.1455 |
| Pulse Biosciences, Inc. | -0.2572 |
| Ultragenyx Pharmaceutical, Inc. | -1.291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 102.00M |
| Revenue (Quarterly) | 358.00M |
| Total Expenses (Quarterly) | 256.00M |
| Enterprise Value | 3.880B |
| Gross Profit Margin (Quarterly) | 82.12% |
| Profit Margin (Quarterly) | 28.49% |
| Earnings Yield | 5.30% |
| Operating Earnings Yield | 9.10% |
| Normalized Earnings Yield | 7.141 |